DWT
IDXX icon

Dorsey & Whitney Trust’s Idexx Laboratories IDXX Stock Holding History

Dorsey & Whitney Trust’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Buy
486
+25
+5% +$16K 0.02% 598
2025
Q4 		$312K Buy
461
+36
+8% +$24.5K 0.02% 542
2025
Q3 		$271K Sell
425
-24
-5% -$14.6K 0.01% 567
2025
Q2 		$241K Buy
+449
New +$215K 0.01% 595
2024
Q4 		– Sell
-811
Closed -$410K – 691
2024
Q3 		$410K Hold
811
– – 0.02% 435
2024
Q2 		$395K Buy
811
+12
+2% +$6.02K 0.03% 396
2024
Q1 		$431K Buy
799
+16
+2% +$8.74K 0.03% 380
2023
Q4 		$435K Buy
783
+302
+63% +$142K 0.03% 372
2023
Q3 		$210K Buy
481
+3
+0.6% +$1.5K 0.02% 536
2023
Q2 		$240K Buy
478
+67
+16% +$32.1K 0.02% 500
2023
Q1 		$206K Buy
+411
New +$197K 0.02% 527
2022
Q2 		– Sell
-378
Closed -$206K – 562
2022
Q1 		$206K Buy
378
+9
+2% +$4.73K 0.02% 529
2021
Q4 		$243K Buy
369
+17
+5% +$10.7K 0.02% 473
2021
Q3 		$219K Hold
352
– – 0.02% 485
2021
Q2 		$223K Buy
+352
New +$194K 0.02% 481

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dorsey & Whitney Trust's IDXX Position: Q1 2026 in Review

Dorsey & Whitney Trust increased its Idexx Laboratories (IDXX) stake by 5.4% in Q1 2026, buying an estimated $16K and bringing the position to 486 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #598.

Dorsey & Whitney Trust first reported a position in IDXX in Q2 2021 and has held it in 15 quarters since. The position peaked at $435K in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Dorsey & Whitney Trust held 486 shares of Idexx Laboratories worth $273K as of Q1 2026.
  • Dorsey & Whitney Trust bought 25 Idexx Laboratories shares in Q1 2026, an estimated $16K.
  • Idexx Laboratories made up 0.02% of Dorsey & Whitney Trust's portfolio in Q1 2026, its #598 holding.
  • Dorsey & Whitney Trust first reported a position in Idexx Laboratories in Q2 2021 and has held it in 15 quarters since.
  • Dorsey & Whitney Trust's Idexx Laboratories position peaked at $435K in Q4 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q1 2026, filed 14 May 2026.